TransGenRx

About:

TransGenRx develops technology to produce protein based drugs by using avian cell line and vector systems.

Website: http://www.tgrxinc.com

Description:

TransGenRx, a biopharmaceutical manufacturing company, has developed technology that significantly reduces the cost of producing protein-based drugs by using a high expressing avian cell line combined with their patented vector system. Patented and patent pending processes allow TGRx to develop custom proteins to meet a wide range of specifications. Use the links on the left to learn more about our team as well as the products and services we offer through our patent and patent pending technologies.

Total Funding Amount:

$6.93M

Headquarters Location:

Baton Rouge, Louisiana, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)tgrx.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2010-10-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai